Nomograms are widely used in cancer prognosis primarily because of their ability to reduce statistical predictive models to a single numerical estimate of the probability of an event, such as death or recurrence, tailored to an individual patient’s profile.[20] Therefore, we set CDCA3 as a prognostic indicator of glioma and established a nomogram with a risk classification system. This evidence concerns the gene CDCA3 and glioma.